(Q39410429)

11 September 2017

title

Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea (English)

1 reference

11 September 2017

0 references

1 reference

Patrick J Coyne

1

1 reference

11 September 2017

Ramakrishnan Viswanathan

series ordinal

2

1 reference

11 September 2017

Thomas J Smith

series ordinal

3

1 reference

11 September 2017

publication date

1 February 2002

1 reference

Journal of Pain and Symptom Management

11 September 2017

published in

1 reference

11 September 2017

volume

23

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

157-160

1 reference

Management of dyspnea and cough in patients with cancer

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Dyspnea in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Non-pharmacological intervention for breathlessness in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Strategies patients use to manage the sensation of dyspnea.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood Gases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Dihydrocodeine for breathlessness in "pink puffers".

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Low-dose nebulized morphine does not improve exercise in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

The use of nebulized opioids for breathlessness: a chart review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Relieving breathlessness with nebulized morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

1 reference

7 January 2021

Nebulized morphine in the palliation of dyspnoea

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Long-term management of respiratory symptoms in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

Acute respiratory depression as a complication of nebulised morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900391-8

7 January 2021

10.1016/S0885-3924(01)00391-8

Identifiers

DOI

1 reference

11 September 2017

1 reference